Noninsulin Glucose-Lowering Therapy

Module Description

This module provides health care professionals with a comprehensive understanding of non-insulin glucose-lowering medications, their mechanisms of action, and the factors influencing the selection of appropriate regimens. Participants will explore the benefits and risks associated with different non-insulin glucose-lowering options, enabling them to make informed decisions in the management of diabetes.

Learning Objectives

At the end of this module, participants will be able to:

Recall noninsulin glucose-lowering medications and their mechanisms of action.
Determine the most appropriate noninsulin glucose-lowering regimen based on individualized factors.
Identify the benefits and risks of different noninsulin glucose-lowering medication options.

Module Faculty

Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP

Dr. Neumiller is vice-chair and the Allen I. White Distinguished Professor in the Department of Pharmacotherapy at Washington State University in Spokane. He is a contributing author for the ADA books Medications for the Treatment of Diabetes and Practical Insulin. A past editor-in-chief for the ADA journal Diabetes Spectrum and past Chair of the ADA’s Professional Practice Committee, he currently serves on the editorial board of BMJ Open Diabetes Research & Care, and is the 2024 President Elect, Health Care & Education for the ADA.

Course Support

If you have questions about this course, please email professionaleducation@diabetes.org.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	1.25 CME Credits 1.25 ABIM-MOC Points 1.25 ACPE Credits 1.25 ANCC Credits 1.25 AAPA Credits 1.25 CDR Credits 1.25 COP Credits

Create Account